Bruno Vanderlinden

机构：Université Libre de Bruxelles, Institut Jules Bordet, Centre Hospitalier Universitaire Brugmann

发表论文 72 篇 · 总被引 2014 次 · h-index 21

代表论文

• Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab (2015 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 105)
• Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score (2022 · British Journal of Cancer · 被引 100)
• Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study (2019 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 76)
• A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours (2018 · Physica Medica · 被引 66)
• 90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer (2018 · EJNMMI Research · 被引 61)
• Prediction of 177 Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study (2023 · Journal of Nuclear Medicine · 被引 53)